Bristol-Myers Squibb Company v. Dr. Reddys Laboratories, Ltd

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Michael A. Shipp · 5,509 cases in index

Docket number

3:19-cv-18686

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

10/03/2019

Date terminated

07/15/2021

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Bristol-Myers Squibb Pharmaceuticals & Biotechnology · 9426 cases
• defendant · Dr. Reddys Laboratories, Inc Pharmaceuticals & Biotechnology · 36 cases

Part of a Larger Litigation Pattern

This is one of 37 Patent - ANDA cases in our index naming DR. REDDYS LABORATORIES, INC — a possible mass-tort or coordinated-litigation cluster.

• Bayer HealthCare Pharmaceuticals Inc v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 10/23/2025
• Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc
  District Court, D. DelawareFiled 07/29/2021
• Merck Sharp & Dohme Corp v. Dr. Reddys Laboratories, Inc
  District Court, D. DelawareFiled 07/15/2021
• Bayer Pharma Ag v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 05/24/2021
• AbbVie Inc v. Dr. Reddys Laboratories, Ltd
  District Court, D. DelawareFiled 07/21/2020
• Merck Sharp & Dohme B.V v. Dr. Reddys Laboratories, Inc
  District Court, D. New JerseyFiled 03/16/2020

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Bristol-Myers Squibb Company v. Dr. Reddys Laboratories, Ltd?

Bristol-Myers Squibb Company v. Dr. Reddys Laboratories, Ltd is a federal patent - anda lawsuit filed on 10/03/2019 in the District Court, D. New Jersey. The case was terminated on 07/15/2021. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 3:19-cv-18686.

When was the case filed?

Bristol-Myers Squibb Company v. Dr. Reddys Laboratories, Ltd was filed on 10/03/2019. It was terminated on 07/15/2021.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.